IVIRMA Middle-East Fertility Clinic, Abu Dhabi, United Arab Emirates.
Obstetrical Department, Women´s University Hospital Tuebingen, Tuebingen, Germany.
PLoS One. 2018 Nov 1;13(11):e0206098. doi: 10.1371/journal.pone.0206098. eCollection 2018.
In recent years there is increasing evidence that elevated progesterone levels during ovarian stimulation for IVF / ICSI have a negative impact on the ART-outcome. However, different progesterone assays were used in the previous studies and different assays might produce varying results. This retrospective study evaluated the reproducibility and reliability of different progesterone assays with a special focus on progesterone levels below 1.5 ng/ml, as this range is crucial for early detection of progesterone rise during ovarian stimulation for IVF. A total of 413 blood samples were categorized in different progesterone ranges and whether they were retrieved on the day of final oocyte maturation and the results were compared regarding their reproducibility and reliability. To compare the reproducibility between the different progesterone assays, the Intraclass Correlation Coefficient (ICC) was calculated and interpretation of the ICC results was done according to Cicchetti, ranging from poor to excellent. The correlation of the assays was excellent when all samples were compared including samples retrieved on day of final oocyte maturation, however in the ranges of progesterone levels 1.0 ng/ml to < 1.5 ng/ml, 0.8 ng/ml to < 1.0 ng/ml and < 0.8 ng/ml, the ICC varied between poor and excellent. The assays "gen III" and "Architect" showed an excellent reproducibility of progesterone results throughout all ranges of progesterone levels. This analysis demonstrates, that different progesterone assays have a limited reproducibility and that the results depend on the assay used and the range of progesterone level. This fact leads to two important conclusions. Firstly the limited reproducibility might lead to substantially different treatment decisions in ovarian stimulation treatment for IVF and secondly critical interpretation of thresholds, provided by meta-analysis, is crucial despite the risk that the so far gained clinical experience might become irrelevant and has to be adjusted to the results, obtained by each assay.
近年来,越来越多的证据表明,体外受精/卵胞浆内单精子注射(IVF/ICSI)中卵巢刺激期间孕酮水平升高对 ART 结局有负面影响。然而,以前的研究中使用了不同的孕酮检测方法,不同的检测方法可能会产生不同的结果。这项回顾性研究评估了不同孕酮检测方法的重现性和可靠性,特别关注孕酮水平低于 1.5ng/ml 的情况,因为这个范围对于早期检测 IVF 卵巢刺激期间孕酮升高至关重要。总共对 413 个血液样本进行了分类,分为不同的孕酮范围,并比较了这些样本在最终卵母细胞成熟当天是否被采集,以及它们的重现性和可靠性。为了比较不同孕酮检测方法的重现性,计算了组内相关系数(ICC),并根据 Cicchetti 的标准对 ICC 结果进行了解释,范围从差到优。当比较所有样本,包括最终卵母细胞成熟当天采集的样本时,所有检测方法的相关性都非常好,然而在孕酮水平 1.0ng/ml 至<1.5ng/ml、0.8ng/ml 至<1.0ng/ml 和<0.8ng/ml 的范围内,ICC 则从差到优不等。检测方法“gen III”和“Architect”在所有孕酮水平范围内均表现出孕酮结果的优异重现性。该分析表明,不同的孕酮检测方法具有有限的重现性,结果取决于所使用的检测方法和孕酮水平范围。这一事实导致了两个重要的结论。首先,有限的重现性可能导致在 IVF 卵巢刺激治疗中做出截然不同的治疗决策。其次,尽管存在风险,即迄今为止获得的临床经验可能变得不相关,并且必须根据每个检测方法的结果进行调整,但仍需要对荟萃分析提供的阈值进行关键解读。